about
Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situHigh multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacyHIV-1 cell to cell transfer across an Env-induced, actin-dependent synapseAvoiding the void: cell-to-cell spread of human virusesMixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvantsThe regulated secretory pathway in CD4(+) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapseStructural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 DonorsA novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environmentInternational network for comparison of HIV neutralization assays: the NeutNet report IIDry roasting enhances peanut-induced allergic sensitization across mucosal and cutaneous routes in miceProduction and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins.Stabilized HIV-1 envelope glycoprotein trimers for vaccine use.Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibitionHigh-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.International network for comparison of HIV neutralization assays: the NeutNet report.Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals.Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteinsMacrophages and HIV-1: An Unhealthy Constellation.Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmissionInterfacial metal and antibody recognitionExpression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicityNew templates for HIV-1 antibody-based vaccine design.Comparison of neutralizing antibody responses elicited from highly diverse polyvalent heterotrimeric HIV-1 gp140 cocktail immunogens versus a monovalent counterpart in rhesus macaquesMembrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission.Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils.Carnauba wax nanoparticles enhance strong systemic and mucosal cellular and humoral immune responses to HIV-gp140 antigen.Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: complete protection of rhesus monkeys from mucosal SHIV challenge.Viral determinants of HIV-1 macrophage tropism.Retroviral spread by induction of virological synapses.Dangerous liaisons at the virological synapse.The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice.The prospects for vaccines against HIV-1: more than a field of long-term nonprogression?V3: HIV's switch-hitter.Fundamental immunology and what it can teach us about HIV vaccine development.Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens.Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine DesignHuman T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycansThe autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation.Regulated secretion from CD4+ T cells.
P50
Q21090535-C17A38D5-730E-41CD-88C7-17DF7DBEBF86Q22242698-148543AC-3070-4501-8448-F69EA43A75BAQ22242967-1EC88C03-FB07-4D72-9797-A99F8927399CQ22251022-2F352D4E-3493-4F6F-970E-4680E9E976D7Q27304735-ABCA21B7-E0E9-4714-B104-189CC1E37E5EQ27349077-8073A1DD-9E2F-4D73-9AED-5B7CC2266C02Q27643993-7BD90C0B-3346-4E9B-B131-2562CADB4D72Q28476693-D5E67629-61E3-46E0-B943-7D1D399C228FQ28730045-C2726FF7-21F7-4A75-A400-CF30DFEAEA2CQ29302052-CFE49E3A-5592-4A60-8CB5-5315153D7EA6Q30358769-6E7CF8A6-84B2-4F2E-A6A1-1AA99D472042Q30490942-CB1E6580-9E8E-464A-BC97-30F0DE89BE80Q30493649-869520CC-C7D4-41BD-B54A-871E78C960BFQ30570557-32330123-5DD8-4689-B552-2A5BEA9D4EF7Q33388659-5860AC42-3CFF-4EFF-95B0-139FDCF9E6BFQ33410826-30359B12-EDBF-4F56-81BC-1F8F4DF5DAA0Q33526340-1F26AF7E-D05B-40E7-87FA-9F1A287E64F0Q33718048-39DE4CD1-B52F-421B-8FD6-08E4A455327EQ33751356-7F50DB9B-AF7F-4349-A644-9B97A688E502Q33856326-7ED0FBC2-99A9-4DFD-B87E-5E1450F3644EQ34049641-820BF046-CE9A-41ED-9172-7069FB843960Q34175370-66D16F0F-CC5F-414F-96AF-0BF2C12EEDC7Q34344323-28E66A83-1A2F-4092-91B9-793390E79EE8Q34663118-B35C3EAF-84E8-4B4F-AAB4-0EA9546134BAQ34735674-771315D8-7DAB-4898-A55D-1A5F39349C7CQ34990389-B8CE6849-9BE5-4594-ABF9-383ED47B335DQ34993838-B094FE5A-F511-426B-9C40-5BF1AD793EF9Q35545292-3D2A3BCD-87F4-4B9E-90E7-574EF417AEE2Q35593158-BBACCE4E-2972-483C-A508-A1A42994A9A6Q35856741-610A6FAD-C386-4F92-A131-33B3D40E6B11Q35877219-68666B2E-18B9-49BD-B2F4-34DA434F4297Q35998757-FF6D5E4B-CE1E-41D4-97D5-70DB33731524Q36041219-B3F1E279-29C5-4C49-BC3D-F5397163262BQ36051661-916F7DB0-479A-4A71-9C2B-612E6DE4327BQ36173020-D1883868-46E5-4D8F-8DD3-AEE1DD7B6918Q36395541-9C70F99F-5176-4739-B45B-BBCDF81AB347Q36447540-E0024400-C61F-4501-BBD5-55FCC505B191Q36464718-ABC76FC5-4DA9-4F26-85DD-D04C71F256D5Q36703636-99718030-0F56-459D-9420-6A4E1E8E58D6Q36982140-556F11C6-8C92-495C-87CD-DC74A879566E
P50
description
researcher ORCID ID = 0000-0001-7170-1937
@en
wetenschapper
@nl
name
Quentin J Sattentau
@ast
Quentin J Sattentau
@en
Quentin J Sattentau
@nl
type
label
Quentin J Sattentau
@ast
Quentin J Sattentau
@en
Quentin J Sattentau
@nl
prefLabel
Quentin J Sattentau
@ast
Quentin J Sattentau
@en
Quentin J Sattentau
@nl
P106
P31
P496
0000-0001-7170-1937